|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 10-20-2004
WASHINGTON (Reuters) - U.S. health officials, stung by political attacks after losing 40 percent of the flu shot supply, got a small break on Tuesday as one vaccine supplier announced it had squeezed out an extra 2.6 million doses.
NEW YORK (Reuters Health) - Some people with depression may refuse treatment because of the associated stigma, but the majority may go untreated simply because it is too expensive, according to the findings of an international study.
NEW YORK (Reuters Health) - Consuming moderate-to-high amounts of coffee is associated with increased levels of several inflammatory markers, a finding that could help explain previous reports linking the beverage to heart disease.
NEW YORK (Reuters Health) - Spinal and non-spinal fractures are reduced by almost a third in women age 80 or older who take a drug called strontium ranelate, European investigators announced at the annual meeting of the American College of Rheumatology that is underway in San Antonio, Texas.
KAMPALA, Uganda (Reuters) - The biggest HIV/AIDS training center in sub-Saharan Africa opened in Uganda Wednesday with officials hopeful it will significantly boost the continent's ability to fight the deadly pandemic.
WASHINGTON (Reuters) - A new study on emergency rooms disputes the common wisdom that the poor and uninsured are filling them up.
BANGKOK (Reuters) - Thailand ordered a cull of 40 tigers suspected of suffering from bird flu Wednesday after seven more of the big cats died, bringing the tiger death toll at an infected zoo to 30.
NEW YORK (Reuters Health) - When it comes to choosing fall-proof footwear, elderly people should wear athletic shoes whenever possible, and avoid going barefoot, new research suggests.
NEW YORK (Reuters Health) - Stopping epidural medications during the last stages of labor does not improve pregnancy outcomes, but it does markedly increase pain, results of a review study suggest.
BUENOS AIRES (Reuters Health) - The first three patients participating in an early test of a "revolutionary" human gene therapy for erectile dysfunction have not developed any treatment-related side effects, according to preliminary results released here this week at a meeting of the International Society for Sexual and Impotence Research.
|
|
